| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | - CEO | KRX SM Exchange | - ISIN |
| South Korea Country | 22 Employees | - Last Dividend | 12 Oct 2020 Last Split | - IPO Date |
BENO TNR, Inc. is a multifaceted company that operates within the construction, robotics, and biotechnology industries. Originally founded in 2001 and known as Benoholdings, Inc., it underwent a rebranding in July 2023 to become BENO TNR, Inc. The company has its headquarters in Seoul, South Korea, and has carved out a niche for itself by integrating innovative technologies into traditional industries. BENO TNR, Inc. is not only involved in the designing and manufacturing of eco-friendly building materials and systems but is also pioneering in the field of robotics and biotechnology, particularly through the development of exoskeleton wearable robots and advancements in medicine via epigenetic modification.
BENO TNR, Inc. specializes in the design, manufacture, and construction of shading systems. These systems are tailored for various buildings, focusing on energy efficiency and the enhancement of indoor environmental quality by controlling the amount of sunlight that enters a space.
The company's eco-friendly flooring solutions are designed with sustainability and environmental responsibility in mind. These flooring options offer a greener alternative to traditional materials, contributing to healthier indoor air quality and offering innovative design possibilities.
BENO TNR, Inc. produces radiant heating panels that offer an efficient method of heating a space. Unlike conventional heating systems, these panels provide warmth directly to the floor or walls of a building, resulting in even heat distribution and enhanced comfort.
XoMotion is a groundbreaking exoskeleton wearable robot developed by BENO TNR, Inc. It is designed to support lower body movements, empowering individuals with mobility impairments to walk and move more freely. This innovative tool is at the forefront of robotics, helping to improve the quality of life for many.
In the realm of biotechnology, BENO TNR, Inc. is making strides in the development of medicine through epigenetic modification. This cutting-edge approach to medicine aims to alter gene expression without changing the DNA sequence, paving the way for new treatments and therapies in various medical fields.